Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2026 -93.75M
June 30, 2026 -89.08M
March 31, 2026 -76.14M
December 31, 2025 -90.83M
September 30, 2025 142.17M
June 30, 2025 -63.14M
March 31, 2025 -61.67M
December 31, 2024 -122.76M
September 30, 2024 -49.69M
June 30, 2024 -33.86M
March 31, 2024 -45.14M
December 31, 2023 -24.59M
September 30, 2023 -30.78M
June 30, 2023 -34.34M
March 31, 2023 -27.88M
December 31, 2022 -23.37M
September 30, 2022 -25.27M
June 30, 2022 -21.93M
Date Value
March 31, 2022 -20.05M
December 31, 2021 -17.26M
September 30, 2021 -12.93M
June 30, 2021 -13.51M
March 31, 2021 -14.73M
December 31, 2020 -11.78M
September 30, 2020 89.96M
June 30, 2020 -13.68M
March 31, 2020 -9.545M
December 31, 2019 -8.922M
September 30, 2019 -10.63M
June 30, 2019 -10.72M
March 31, 2019 -10.39M
December 31, 2018 -7.785M
September 30, 2018 -9.692M
June 30, 2018 -6.108M
March 31, 2018 -5.743M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 67.40M
Xencor, Inc. 0.838M
ACADIA Pharmaceuticals, Inc. 10.26M
BioMarin Pharmaceutical, Inc. 165.35M
MediciNova, Inc. -1.92M